Literature DB >> 28031684

Myectomy-Like Extended Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy.

Denisa Jahnlová1, Pavol Tomašov1, Josef Veselka1.   

Abstract

Currently, two therapeutic options are available for patients with drug-resistant obstructive hypertrophic cardiomyopathy. While there is a tendency in extended myectomy to perform a larger septal reduction to eliminate left ventricular outflow tract gradient more effectively, there has been a trend in recent years toward using lower dosages of alcohol during alcohol septal ablation (ASA) to reduce the risk of arrhythmic complications. We report a case of a symptomatic patient with severe septal hypertrophy who underwent an extended ASA of three septal branches. This led to a result similar to an extended myectomy with a favorable short-term follow-up.

Entities:  

Keywords:  coronary artery; hypertrophic cardiomyopathy; symptomatic

Year:  2015        PMID: 28031684      PMCID: PMC5186332          DOI: 10.1055/s-0035-1564660

Source DB:  PubMed          Journal:  Int J Angiol        ISSN: 1061-1711


  4 in total

1.  2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.

Authors:  Bernard J Gersh; Barry J Maron; Robert O Bonow; Joseph A Dearani; Michael A Fifer; Mark S Link; Srihari S Naidu; Rick A Nishimura; Steve R Ommen; Harry Rakowski; Christine E Seidman; Jeffrey A Towbin; James E Udelson; Clyde W Yancy
Journal:  Circulation       Date:  2011-11-08       Impact factor: 29.690

2.  Long-term effects of varying alcohol dosing in percutaneous septal ablation for obstructive hypertrophic cardiomyopathy: a randomized study with a follow-up up to 11 years.

Authors:  Josef Veselka; Pavol Tomašov; David Zemánek
Journal:  Can J Cardiol       Date:  2011-10-14       Impact factor: 5.223

3.  Surgical septal myectomy versus alcohol septal ablation: assessing the status of the controversy in 2014.

Authors:  Barry J Maron; Rick A Nishimura
Journal:  Circulation       Date:  2014-10-28       Impact factor: 29.690

4.  Survival of patients ≤ 50 years of age after alcohol septal ablation for hypertrophic obstructive cardiomyopathy.

Authors:  Josef Veselka; Jan Krejčí; Pavol Tomašov; Denisa Jahnlová; Tomáš Honěk; Jaroslav Januška; Marian Branny; David Zemánek
Journal:  Can J Cardiol       Date:  2014-04-03       Impact factor: 5.223

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.